Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Oded Goren

Neurological Surgery Danville, PA Medical Doctor

NPI 1003299629 CMS profile 1343502

100 N Academy Ave, Danville, PA 17822

Open in the dashboard

General payments

$448,238

408 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$60,283 paid to institutions, not to them · program years 2021–2024

Through program year 2025, Oded Goren of Danville, PA is reported in the CMS Open Payments database as having received $448,238 across 408 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $60,283 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $168,769 118
2024 General $153,838 137
2023 General $95,251 80
2022 General $18,579 44
2021 General $10,991 15
2020 General $258 5
2019 General $551 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Oded Goren
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Oded Goren were reported at $168,769. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Oded Goren Neurological Surgery median Middle half National median
2019 $551 $582 $138–$3,006 $163
2020 $258 $294 $76–$2,174 $114
2021 $10,991 $387 $105–$2,432 $132
2022 $18,579 $542 $139–$2,989 $149
2023 $95,251 $534 $145–$2,697 $160
2024 $153,838 $574 $155–$3,046 $164
2025 $168,769 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $324,531 276 payments
  2. Stryker Corporation $75,814 93 payments
  3. Route 92 Medical, Inc. $38,156 10 payments
  4. Rapid Medical LTD $8,869 15 payments
  5. Penumbra, Inc. $260 2 payments
  6. Medtronic, Inc. $233 3 payments
  7. DePuy Synthes Sales Inc. $158 4 payments
  8. Imperative Care, INc $145 3 payments
  9. Silk Road Medical, Inc. $52 1 payment
  10. Contego Medical, Inc $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $229,657 73 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $169,430 88 payments
  3. Travel and Lodging $41,373 128 payments
  4. Food and Beverage $7,778 119 payments
Products named General payments · program years 2019–2025
  1. WEB ANEURYSM EMBOLIZATION SYSTEM $262,771 219 payments
  2. STENT Neurological Product $56,002 30 payments
  3. STENT Neurological Product $33,944 12 payments
  4. 8F BASE CAMP SHEATH SYSTEM $14,215 5 payments
  5. TARGET $12,000 13 payments
  6. TIGERTRIEVER 17 REVASCULARIZATION DEVICE $8,869 15 payments
  7. COMANECI 17 $8,869 15 payments
  8. SURPASS EVOLVE $7,975 10 payments
  9. SOFIA 6F-131CM STR $5,819 4 payments
  10. 088 ACCESS SYSTEM $4,000 1 payment
  11. Other $28,255 102 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

17

Median for Neurosurgery: 83

Drug cost

$236

Median for Neurosurgery: $872

Branded share of claims

100%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 17 $236

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$62,860

Medicare's payments for the services billed

Medicare patients

115

Average age 74

Services billed

394

64 women, 51 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 41%
Diabetes 40%
Ischemic heart disease 35%
Depression 35%
Chronic kidney disease 30%
COPD 29%
Atrial fibrillation 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

408 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record